G-5758
고객리뷰
Based on 1 Customer Validation
G-5758 is a selective and orally effective IRE1α inhibitor with an IC50 of 38 nM (detected by the XBP1s luciferase reporter cell assay). G-5758 is still well tolerated in rats at oral doses up to 500 mg/kg. G-5758 can be used in the research of multiple myeloma.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- Purity: 98.91%
- CAS No.: 2413455-99-7
- 화학식: C27H24F4N6O3S
- 분자량:588.58
-
보관:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
You May Still Need
Biological Activity
제품 설명
G-5758 is a selective and orally effective IRE1α inhibitor with an IC50 of 38 nM (detected by the XBP1s luciferase reporter cell assay). G-5758 is still well tolerated in rats at oral doses up to 500 mg/kg. G-5758 can be used in the research of multiple myeloma[1].
In Vivo
G-5758 (500 mg/kg; oral administration; twice daily; 7 days) is well tolerated in male Sprague-Dawley rats, with a Cmax of 104,000 ng/mL and an AUC of 909,000 h·ng/mL[1].
G-5758 (250 mg/kg; oral administration; twice daily; 4 days) can suppress XBP1s levels for 12 hours in the KMS-11 xenograft mouse model, and then the XBP1s levels reboundes[1].
Pharmacokinetic Analysis in Mice[1]
G-5758 (250 mg/kg; oral administration; twice daily; 4 days) can suppress XBP1s levels for 12 hours in the KMS-11 xenograft mouse model, and then the XBP1s levels reboundes[1].
Pharmacokinetic Analysis in Mice[1]
| dose (mg/kg)/route | CL (mL/min/kg) | Vss (L/kg) | t1/2 (h) | %F |
| 1 (IV)/10 (PO) | 33.9 | 1.05 | 0.55 | 149 |